CAR NK ther­a­py looks durable in a small tri­al, giv­ing in­sight in­to large Take­da study

An “off-the-shelf” cell ther­a­py en­gi­neered us­ing nat­ur­al killer cells re­sult­ed in last­ing re­spons­es in a small clin­i­cal tri­al for cer­tain lym­phomas and leukemia, ac­cord­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER